We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYRN
3026
DELISTED
CYREN Ltd.
CYRN
$4K ﹤0.01%
84
+75
+833% +$3.25K
AERI
3027
DELISTED
Aerie Pharmaceuticals
AERI
$4K ﹤0.01%
70
-4,581
-98% -$278K
AXU
3028
DELISTED
Alexco Resource Corp
AXU
$4K ﹤0.01%
1,900
-247
-12% -$335
HSTO
3029
DELISTED
Histogen Inc. Common Stock
HSTO
$4K ﹤0.01%
5
-28
-85% -$25.9K
MGP
3030
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$4K ﹤0.01%
+150
New +$4.4K
PCI
3031
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
$4K ﹤0.01%
+200
New +$4.52K
FLXN
3032
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
+160
New +$3.92K
SQBG
3033
DELISTED
Sequential Brands Group, Inc.
SQBG
$4K ﹤0.01%
62
-125
-67% -$10.6K
MFNC
3034
DELISTED
Mackinac Financial Corporation
MFNC
$4K ﹤0.01%
+221
New +$3.49K
DPLO
3035
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$4K ﹤0.01%
205
-5,505
-96% -$108K
NETS
3036
DELISTED
Netshoes (Cayman) Limited
NETS
$4K ﹤0.01%
500
-4,965
-91% -$45.3K
ECYT
3037
DELISTED
Endocyte, Inc. Common Stock
ECYT
$4K ﹤0.01%
+910
New +$4.33K
EDGW
3038
DELISTED
Edgewater Technology Inc
EDGW
$4K ﹤0.01%
593
+199
+51% +$1.27K
RPXC
3039
DELISTED
RPX Corporation
RPXC
$4K ﹤0.01%
290
-3,671
-93% -$48.5K
BBG
3040
DELISTED
Bill Barrett Corp
BBG
$4K ﹤0.01%
809
-648
-44% -$3.32K
BSFT
3041
DELISTED
BroadSoft, Inc.
BSFT
$4K ﹤0.01%
72
-4,200
-98% -$229K
BXE
3042
DELISTED
Bellatrix Exploration Ltd.
BXE
$4K ﹤0.01%
2,080
-9,705
-82% -$20.8K
CDOR
3043
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$4K ﹤0.01%
486
+447
+1,146% +$4.5K
EMMS
3044
DELISTED
Emmis Communications Corp
EMMS
$4K ﹤0.01%
+1,321
New +$4.38K
STFC
3045
DELISTED
State Auto Financial Corp
STFC
$4K ﹤0.01%
139
-2,536
-95% -$68.5K
LLEX
3046
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$4K ﹤0.01%
716
-8,618
-92% -$41.6K
EFII
3047
DELISTED
Electronics for Imaging
EFII
$4K ﹤0.01%
125
-6,774
-98% -$227K
DOC
3048
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4K ﹤0.01%
200
-16,453
-99% -$295K
DWIN
3049
DELISTED
Invesco DWA Tactical Multi-Asset Income ETF
DWIN
$4K ﹤0.01%
+137
New +$3.71K
SBB
3050
DELISTED
SUSSEX BANCORP
SBB
$4K ﹤0.01%
153
+53
+53% +$1.39K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.